Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.
Stock data | 2024 | Change |
---|---|---|
Price | $3.13 | N/A |
Market Cap | $1.30B | N/A |
Shares Outstanding | 416.45M | N/A |
Employees | 1.66K | N/A |